BioCardia, Inc. ( BCDA) - Key Metrics
BCDA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2025Q1 | ? | ? | ? | ? |
BCDA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | ? |
BCDA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -12.70% | ? |
| 2025Q4 | -18.62% | ? |
| 2025Q3 | -20.65% | ? |
| 2025Q2 | -16.72% | ? |
| 2025Q1 | -23.21% | ? |
BCDA
Price: $0.85
52 week price:
Earnings Per Share: -0.85 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 50500
Market Capitalization: 5.9 million